Table 2.
Prevalence of suicidal ideation and suicide attempts in the control and migraine groups.
| Episodic migraine | |||||||
|---|---|---|---|---|---|---|---|
| Outcome / subgroup | Control | 1–4 days/month | 5–8 days/month | 9–14 days/month | ≥15 days /month | P value§ | P value‡ |
| SUICIDAL IDEATION | |||||||
| Total | 5 (2.8) | 37 (18.1) | 16 (15.1) | 29 (23.8) | 27 (28.1) | <0.001 | 0.137 |
| With aura | 0 (0.0) | 14 (22.2) | 9 (25.0) | 13 (37.1) | 17 (47.2) | <0.001 | 0.030 |
| Without aura | 5 (2.8) | 23 (16.3) | 7 (10.0) | 16 (18.4) | 10 (16.7) | <0.001 | 0.606 |
| SUICIDE ATTEMPT | |||||||
| Total | 0 (0.0) | 4 (2.0) | 2 (1.9) | 7 (5.7) | 6 (6.3) | <0.001 | 0.103 |
| With aura | 0 (0.0) | 2 (3.2) | 2 (5.6) | 4 (11.4) | 5 (13.9) | <0.001 | 0.015 |
| Without aura | 0 (0.0) | 2 (1.4) | 0 (0.0) | 3 (3.4) | 1 (1.7) | 0.064 | 0.599 |
§,
Linear trend of Cochran–Armitage chi-square test;
‡,
Linear contrast in the logistic regression adjusted for age, sex, marital status, years of education, employment status, alcohol consumption, Hospital Anxiety, and Depression Subscales; Beck Depression Inventory scores, Hospital Anxiety and Depression Subscales for anxiety and depression, and Pittsburgh Sleep Quality Index total scores.